Riskpilot← Back to searchSign inGet full accessDoktor Herber AB
ABIn liquidationOrg 5590592944StockholmGeneral medical practice activities · NACE 8621Est. 20161 employees
Revenue 2025
SEK -3
EBITDA margin
1016266.7%
-41% vs 2024
Equity ratio
96.4%
Financial strength
Net profit 2025
SEK -30K
-62% vs 2024
| Revenue | SEK -3 | — |
| EBITDA | SEK -30K | -41% |
| Net profit | SEK -30K | -62% |
| Total assets | SEK 185K | -14% |
| Equity | SEK 179K | -15% |
| Employees | 1 | — |
Legal name
Doktor Herber AB
Org number
5590592944
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 april 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva läkarkonsultverksamhet inom hälso- och sjukvård med huvudinriktning på specialistområdet allmänmedicin, medicinskt orienterad föreläsning och utbildning, forskning och utveckling av patent, förvalta aktier, värdepapper, fast egendom samt idka därmed förenlig verksamhet.
Address
Stockholm
Email
christoffer.hamilton@schjodt.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 1 230 | 1 383 | 800 | 0 | −0 | 0 | 0 | −0 |
| Staff expenses | — | — | — | — | — | — | −11 | — | −0 | — |
| EBITDA | 407 | −116 | 295 | 235 | −40 | −114 | −46 | −24 | −22 | −30 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | — | −0 | — | — |
| EBIT | 407 | −116 | 295 | 235 | −40 | −114 | −46 | −24 | −22 | −30 |
| Net financials | — | — | −1 | — | — | — | 0 | 2 | 3 | — |
| Profit before tax | 407 | −116 | 220 | 176 | 86 | −106 | −46 | −22 | −19 | −30 |
| Tax | −0 | −90 | −49 | −37 | −85 | 33 | — | 7 | — | — |
| Net profit | 407 | −206 | 171 | 139 | 1 | −73 | −46 | −15 | −19 | −30 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 472 | 304 | 460 | 750 | 415 | 311 | 265 | 237 | 216 | 185 |
| Equity | 457 | 91 | 223 | 361 | 362 | 289 | 243 | 228 | 209 | 179 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | — | — |
| Short-term debt | 15 | 213 | 164 | 256 | 46 | 22 | 22 | 9 | 7 | 7 |
| Total debt | 15 | 213 | 164 | 256 | 46 | 22 | 22 | 9 | 7 | 7 |
EBITDA margin
-3048800.0%
This company
15.8%
Market median
-19296303% vs market
20162025
Equity ratio
96.4%
This company
38.2%
Market median
+152% vs market
20162025
Return on equity
-17.0%
This company
18.4%
Market median
-192% vs market
20162025
Net profit margin
-3048800.0%
This company
8.1%
Market median
-37639606% vs market
20162025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20162025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-04-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CH Liquidator | Liquidator | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doktor Herber AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christoffer Hamilton | Liquidator | 0 companies |
| Hjalmar Michael Damko | Deputy Board Member | 0 companies |
| Anna Kristina Eleonora Herber | Board of Directors | 0 companies |
| Joy Andersson | Deputy Board Member | 0 companies |